technetium Tc 99m-hynic-folate

Known as: Tc 99m-hynic-folate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2017
01220022017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
INTRODUCTION Prostate-specific membrane antigen (PSMA) is a well-established target in the development of radiopharmaceuticals… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
A convenient strategy to radiolabel a hydrazinonicotonic acid (HYNIC)-derived tetrazine with 99mTc was developed, and its utility… (More)
Is this relevant?
2015
2015
Immobilization of enzymes on solid supports has been widely used to improve enzyme recycling, enzyme stability, and performance… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2010
2010
Integrin αvβ3 has been well-documented as one of the key players in the process of tumor angiogenesis. Radiolabeled RGD (Arg-Gly… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
This report describes the synthesis of two new cyclic RGD (Arg-Gly-Asp) dimers, 3 (E[G(3)-c(RGDfK)](2)) and 4 (G(3)-E[G(3)-c… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Angiogenesis is a fundamental feature of tumor development, and therefore, the tracers for molecular imaging of specific… (More)
Is this relevant?
2006
2006
At all stages of the disease, serious difficulties are encountered in the imaging diagnosis of carcinoids. Somatostatin receptor… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 2
Is this relevant?
2004
2004
BACKGROUND Our goal was the efficient labelling of highly purified human gammaglobulin. This radioactive protein fraction can be… (More)
Is this relevant?
2003
2003
Two prototype phosphine-containing HYNIC chelators, HYNIC-Kp-DPPB and HYNIC-Ko-DPPB (HYNIC = 6-hydrazinonicotinamide; K = lysine… (More)
Is this relevant?
2002
2002
The clinical potential of 111In and 90Y labelled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugated Tyr3… (More)
Is this relevant?